Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Comparative PKD1 and PKD2 Missense Variant Profiling Aids Molecular Diagnoses and Reveals Common Pathomechanisms and Variant Subtypes across the ADPKD Spectrum
Gainullin, Vladimir G. , Heyer, Christina M., Elbarougy, Doaa E. , Senum, Sarah R. , Sun, Xiaobo , Yang, Hana , Senum, Sarah R , Elbarougy, Doaa E , Sieben, Cynthia J. , Wang, Zhifei , Sturmlechner, Ines , Yu, Yong , Harris, Peter C.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.202471vvcgzj Get It

Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections
Barwise, Amelia , Herasevich, Svetlana , Minteer, Sarah A. , Barwise, Amelia K , Tekin, Aysun , Gajic, Ognjen

Mayo Clinic

Applied Clinical Informatics | October 25, 2024 | Volume: 16 | Issue: 01 | Pages: 223-233

10.1055/a-2451-9046 | PMID 39454642 Get It

Abstract Objectives This study aimed to evaluate critical care provider perspectives about diagnostic practices for rare and atypical infections and the potential for using artificial intelligence (AI) as a decision support system (DSS). Methods We conducted an anonymous web-based survey among critical care providers at Mayo Clinic Rochester between November 25, 2023, and January 15, 2024, to evaluate their experience with rare and atypical infection diagnostic processes and AI-based DSSs. We also assessed the perceived usefulness of AI-based DSSs, their potential impact on improving diagnostic practices for rare and atypical infections, and the perceived risks and benefits of their use. Results A total of 47/143 providers completed the survey. Thirty-eight out of 47 agreed that there was a delay in diagnosing rare and atypical infections. Among those who agreed, limited assessment of specific patient factors and failure to consider them were the most frequently cited important contributing factors (33/38). Thirty-eight out of 47 reported familiarity with the AI-based DSS applications available to critical care providers. Less than half (18/38) thought AI-based DSSs often provided valuable insights into patient care, but almost three-quarters (34/47) thought AI-based DDSs often provided valuable insight when specifically asked about their ability to improve the diagnosis of rare and atypical infections. All respondents rated reliability as important in enhancing the perceived utility of AI-based DSSs (47/47) and almost all rated interpretability and integration into the workflow as important (45/47). The primary concern about implementing an AI-based DSS in this context was alert fatigue (44/47). Conclusion Most critical care providers perceive that there are delays in diagnosing rare infections, indicating inadequate assessment and consideration of the diagnosis as the major contributors. Reliability, interpretability, workflow integration, and alert fatigue emerged as key factors impacting the usability of AI-based DSS. These findings will inform the development and implementation of an AI-based diagnostic algorithm to aid in identifying rare and atypical infections.
Human sympathetic neuronal discharge and recruitment patterns regulate neuropeptide Y bioavailability
Limberg, Jacqueline K. , Wiggins, Chad C. , Spafford, Julia, Iannarelli, Nathaniel , Senefeld, Jonathon W. , Nicholson, Wayne T. , Joyner, Michael J. , Shoemaker, J. Kevin , Klassen, Stephen A , Limberg, Jacqueline K , Harvey, Ronée E , Wiggins, Chad C , Senefeld, Jonathon W , Curry, Timothy B. , Joyner, Michael J , Shoemaker, J Kevin , Baker, Sarah E , Spafford, Julia E , Klassen, Stephen A. , Harvey, Ronée E. , Baker, Sarah E.

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | October 25, 2024 | Volume: 327 | Issue: 6 | Pages: H1599-H1605

10.1152/ajpheart.00639.2024 | PMID 39453430 Get It

The purpose of sympathetic neuronal discharge and the recruitment of neuronal subpopulations for human circulatory homeostasis remains unknown. This study tested the hypothesis that sympathetic neuronal discharge and recruitment patterns regulate neuropeptide Y (NPY) bioavailability. Across baseline and an intravenous dexmedetomidine infusion (α2-adrenergic agonist) sympathetic action potential (AP) frequency and total sympathetic AP clusters were associated with NPY bioavailability. This is the first study to report that sympathetic neuronal discharge and recruitment patterns regulate NPY bioavailability to support circulatory homeostasis in humans.
Survey on Patient Perception of At‐Home Bacterial Biofilm Control in Relation to Peri‐Implant Soft Tissue Health
Hoerler, Sarah B, Murray, Whitnee R., Zhou, Miao Xian , Mueller, Erin B, Mueller, Erin B.

Mayo Clinic

International Journal of Dental Hygiene | October 25, 2024 | Volume: 23 | Issue: 2 | Pages: 415-421

10.1111/idh.12860 | PMID 39449168 Get It

ABSTRACT Objective Bacterial biofilm control around dental implants is critical for the health of the peri‐implant soft tissue and longevity of dental implants. The patient's role in regular biofilm removal around dental implants is just as important as that of the dental hygienist. The purpose of this study is to identify the relationship between at‐home dental implant care and patients' perceptions of peri‐implant soft tissue health. Methods A 15‐item paper survey was distributed to adult patients undergoing professional dental hygiene maintenance at a specialty dental practice within a 3‐month period and had at least one dental implant. Survey items included participant demographics, patient‐reported adjunctive aids for dental implants and patient perceptions of dental implant oral hygiene practices and peri‐implant soft tissue health. Results There was a statistical difference between time spent cleaning dental implants and peri‐implant soft tissue health. An association was found between patients who reported spending more time cleaning their dental implants and less bleeding ( p = 0.046/54%), gingival inflammation ( p = 0.026/58%) and gingival tissue redness ( p = 0.036/53%). Additionally, patients who more frequently underwent professional dental hygiene maintenance perceived less gingival inflammation ( p = 0.001/66%). Conclusion To promote peri‐implant soft tissue health and reduce oral biological complications, best practice guidelines should be implemented, including optimal at‐home dental implant care and regular professional dental hygiene maintenance.
Achieving RoutIne Screening for Emotional health (ARISE) in pediatric subspecialty clinics
Zahidy, Misk Al, Mulholland, Hannah , Particelli, Britt, Olson, J., Campagna, Allegra, Chavez, Maria , McCarthy, Sarah , McCarthy, Sarah R. , Al Zahidy, Misk, Gionfriddo, Michael R. , Olson, Janelle, Mateo Chavez, Maria B, McCarthy, Sarah R , Montori, Víctor M. , Campagna, Allegra, McCarthy, Sarah R.

Mayo Clinic

Journal of Pediatric Psychology | October 23, 2024 | Volume: 50 | Issue: 1 | Pages: 141-149

10.1093/jpepsy/jsae081 | PMID 39441705 Get It

Abstract Objective This study aims to describe the experience of implementing a psychosocial distress screening system for children with serious or chronic medical conditions. Methods Achieving RoutIne Screening for Emotional health (ARISE) was developed to systematically evaluate psychosocial distress in children with serious medical or chronic medical illnesses, by integrating patient-reported outcome measures (PROM) into care delivery. ARISE was developed using a user-centered approach with extensive input from patients, families, and healthcare professionals to overcome barriers to routine PROM collection and integration into care as usual. It comprises a system to capture PROMs and then relay results to clinicians for changing care. We sought to implement ARISE at four subspecialty pediatric clinics caring for patients with cystic fibrosis, sickle cell disease, hemophilia, and neurological malignancy. Results Problems with acceptability, appropriateness, and feasibility represented barriers to implementation which were overcome by modifying the intervention using stakeholder input during the planning phase, leading to broad program acceptance. ARISE was implemented in three of the four clinics, in which 79.8% of eligible children and their family completed PROMs. Conclusion The ARISE program demonstrated the feasibility and effectiveness of integrating psychosocial screenings into subspecialty pediatric clinics, thereby enhancing the identification and management of psychosocial issues in children with serious and chronic medical illnesses.
Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer
Long, Jessica B., Sprenkle, Preston C. , Kim, Isaac Yi , Saperstein, Lawrence, Rabil, Maximilian , Ghaffar, Umar , Karnes, R. Jeffrey , Ma, Xiaomei, Gross, Cary P. , Kunst, Natalia , Westvold, Sarah J. , Wang, Shi‐Yi , Leapman, Michael

Mayo Clinic

JAMA Network Open | October 23, 2024 | Volume: 7 | Issue: 10 | Pages: e2440591

10.1001/jamanetworkopen.2024.40591 | PMID 39441595 Get It

ImportanceAlthough prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown improved sensitivity and specificity compared with conventional imaging for the detection of biochemical recurrent (BCR) prostate cancer, the long-term outcomes of a widespread shift in imaging are unknown.ObjectiveTo estimate long-term outcomes of integrating PSMA-PET into the staging pathway for recurrent prostate cancer.Design, Setting, and ParticipantsThis decision analytic modeling study simulated outcomes for patients with BCR following initial definitive local therapy. Inputs used were from the literature and a retrospective cohort study conducted at 2 institutions. The base case analysis assumed modest benefits of earlier detection and treatment, and scenario analyses considered prostate-specific antigen (PSA) level at imaging and different outcomes of earlier vs delayed treatment. The analysis was performed between April 1, 2023, and May 1, 2024.Exposures(1) Immediate PSMA-PET imaging, (2) conventional imaging (computed tomography and bone scan [CTBS]) followed by PSMA-PET if CTBS findings were negative or equivocal, and (3) CTBS alone.Main Outcomes and MeasuresThe main outcomes were detection of metastases, deaths from prostate cancer, and life-years and quality-adjusted life-years (QALYs) gained.ResultsThe model estimated that per 1000 simulated patients with BCR (assumed median age, 66 years), PSMA-PET is expected to diagnose 611 (95% uncertainty interval [UI], 565-656) patients with metastasis compared with 630 (95% UI, 586-675) patients diagnosed using CTBS followed by PSMA-PET and 297 (95% UI, 202-410) patients diagnosed using CTBS alone. Moreover, the estimated number of prostate cancer deaths was 512 (95% UI, 472-552 deaths) with PSMA-PET, 520 (95% UI, 480-559 deaths) with CTBS followed by PSMA-PET, and 587 (95% UI, 538-632 deaths) with CTBS alone. Imaging with PSMA-PET yielded the highest number of QALYs, which were 824 (95% UI, 698-885) higher than CTBS. These results differed by PSA level at the time of testing, with the highest incremental life-years and QALYs and lowest number of deaths from prostate cancer among patients with PSA levels of at least 5.0 ng/mL. Finally, the estimates were sensitive to the expected benefit of initiating therapy for recurrent prostate cancer earlier in the disease course.Conclusions and RelevanceThe results of this decision-analytic model suggest that upfront PSMA-PET imaging for the evaluation of BCR is expected to be associated with reduced cancer mortality and gains in life-years and QALYs compared with the conventional imaging strategy, assuming modest benefits of earlier detection and treatment.
The diagnostic challenge of differentiating tumefactive multiple sclerosis (TMS) from other brain lesions: a case report and literature review on a rare subtype of MS
Gill, Anosh, Eltawansy, Sherif , Karamat, Riyan Imtiaz , Esposito, Sarah , Karamat, Shayan Imtiaz, Aamir, Minahil , Akilimali, Aymar , Akilimali, Aymar , Nadeem, Zain Ali , Anwaar, Adeel

Mayo Clinic

Annals of Medicine & Surgery | October 23, 2024 | Volume: 86 | Issue: 12 | Pages: 7418-7422

10.1097/ms9.0000000000002687 | PMID 39649871 Get It

Introduction and importance: This case report is a clinical diagnosis walk through of a rare subtype of multiple sclerosis (MS). It gives an overview of how tumefactive multiple sclerosis (TMS) is systematically narrowed down as the definitive diagnosis. Case presentation: This 29-year-old male patient presented to the emergency department. He collapsed after experiencing pain over his right frontotemporal region followed by a seizure witnessed by his family. Magnetic Resonance Imaging of the brain displayed diffuse enlargement and abnormal T2 weighted and FLAIR hyperintense signals in the diagnostic impressions described by the radiologist of the right temporoparietal region. Clinical discussion: Liquefactive multiple sclerosis, also known as tumefactive multiple sclerosis or Marburg-type multiple sclerosis, is a rare subtype of the neurological disorder that can be difficult to diagnose. Unlike the traditional form of MS, TMS can present as a brain tumor and must be diagnosed with a biopsy rather than via MRI and clinical findings alone. Patients can typically present with headache, cognitive abnormalities, mental confusion, aphasia, apraxia, seizures, and weakness. Here, the authors discuss the presentation, disease diagnosis process and patient management. Conclusion: The patient was stabilized and discharged with a referral to the neurosurgery and neurology departments for outpatient consultation for future clinical management and treatment of their condition.
Aging, brain-derived neurotrophic factor, and allergen-induced pulmonary responses in mice
Drake, Li Y. , Roos, B., Wicher, Sarah A. , Khalfaoui, Latifa, Nesbitt, Lisa, Pabelick, Christina M. , Prakash, Y. S. , Roos, Benjamin B, Nesbitt, Lisa L, Pabelick, Christina M , Prakash, Y S , Drake, Li , Fang, Yun Hua

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | October 22, 2024 | Volume: 328 | Issue: 2 | Pages: L290-L300

10.1152/ajplung.00145.2024 | PMID 39437757 Get It

The pathogenesis of asthma in elderly is not well understood. Using a mouse model of asthma, we show that aging results in decreased lung function and less responsiveness to allergen exposure, impacted by locally produced brain-derived neurotrophic factor. Aging also decreases allergen-induced inflammation but increases airway remodeling and senescence. Our results suggest that senescence pathways may contribute to asthma pathogenesis in elderly.
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Aldoss, Ibrahim , Kopmar, Noam E. , Lin, Chenyu , Dekker, Simone E. , Gupta, Vishal, O’Connor, Timothy E. , Jeyakumar, Nikeshan , Muhsen, Ibrahim N. , Valtis, Yannis K. , Zhang, Amy , Miller, Kate , Ahmed, Mohamed , Schwartz, Marc S. , Tracy, Sean , Mukherjee, Akash , Ladha, Abdullah , Guzowski, Caitlin, Hoeg, Rasmus T. , Moore, Jozal , Connor, Matthew P. , Hill, LaQuisa C. , Tsai, Stephanie B., Sasine, Joshua , Solh, Melhem , Koura, Divya, Veeraputhiran, Muthu, Park, Jae H. , Bachanová, Veronika , Galal, Ahmed , Pullarkat, Vinod , Muffly, Lori , Oliai, Caspian , Yaghmour, George , Sutherland, Katherine, Zambrano, Héctor, Bradshaw, Danielle , Kubiak, Michal , Mountjoy, Luke , Malik, Shahbaz A. , Shaughnessy, Paul , Stefan, Maryann, O'Dwyer, Kristen M., Blunk, Betsy, Bishop, Michael R. , Aldoss, Ibrahim , Kopmar, Noam E , Lin, Chenyu , Gupta, Vishal K , Muhsen, Ibrahim N , Valtis, Yannis , Miller, Katharine , Chen, Evan , Mercadal, Santiago , Tracy, Sean I , Dholaria, Bhagirathbhai R , Battiwalla, Minoo , Logan, Aaron C , Ladha, Abdullah , Hilal, Talal , Connor, Matthew , Hill, LaQuisa C , Sasine, Joshua , Solh, Melham M , Kota, Vamsi , Frey, Noelle V , Park, Jae H , Luskin, Marlise R , Stock, Wendy , Cassaday, Ryan D , Muffly, Lori , Bachanova, Veronika , Roloff, Gregory W. , Ahmed, Naveed, Dykes, Kaitlyn C. , Schwartz, Marc, Dholaria, Bhagirathbhai , Battiwalla, Minoo , Hilal, Talal , Tsai, Stephanie B., Kota, Vamsi , Leonard, Jessica T , Frey, Noelle V. , Stock, Wendy , Cassaday, Ryan D. , Shah, Bijal , Faramand, Rawan , Oliai, Caspian H , Majhail, Navneet S. , Mathews, John Abraham , Advani, Anjali S. , O'Dwyer, Kristin , Lee, Catherine J , Bishop, Michael Russell

Mayo Clinic

Journal of Clinical Oncology | October 17, 2024 | Volume: 43 | Issue: 5 | Pages: 558-566

10.1200/jco.24.00321 | PMID 39418622 Get It

PURPOSE On the basis of the results of the ZUMA-3 trial, brexucabtagene autoleucel (brexu-cel), a CD19-directed chimeric antigen receptor T-cell therapy, gained US Food and Drug Administration approval in October 2021 for adults with relapsed/refractory (R/R) B-cell ALL (B-ALL). We report outcomes of patients treated with brexu-cel as a standard therapy. METHODS We developed a collaboration across 31 US centers to study adults with B-ALL who received brexu-cel outside the context of a clinical trial. Data were collected retrospectively from October 2021 to October 2023. Toxicities were graded per American Society for Transplantation and Cellular Therapy guidelines for cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). RESULTS At the time of data lock, 204 patients had undergone apheresis and 189 were infused. Median follow-up time was 11.4 months. Forty-two percent of patients received brexu-cel in morphologic remission and would have been ineligible for participation in ZUMA-3. After brexu-cel, 151 achieved complete remission (CR), of which 79% were measurable residual disease (MRD) negative remissions. Median progression-free survival (PFS) was 9.5 months and median overall survival was not reached. Grade 3-4 CRS or ICANS occurred in 11% and 31%, respectively. In multivariable analysis, patients receiving consolidative hematopoietic cell transplantation (HCT; hazard ratio, 0.34 [95% CI, 0.14 to 0.85]) after brexu-cel had superior PFS compared with those who did not receive any consolidation or maintenance therapy. CONCLUSION Similar to ZUMA-3, high rates of MRD-negative CR were observed after brexu-cel treatment for R/R B-ALL. The use of HCT as consolidation after brexu-cel resulted in improved PFS.
Impact of Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Screening Tests on Duration of Vancomycin Therapy for Skin and Soft Tissue Infections
Jantzen, Aleesha, Woolever, Nathan L. , Treu, M., Stakston, Jaclyn , Cai, Songlin , Tempelis, Jennifer, Kujak, Richard Charles , Dierkhising, Ross , Dababneh, Ala S. , Lessard, Sarah , Woolever, Nathan , Treu, Megan , Jantzen, Aleesha

Mayo Clinic

Hospital Pharmacy | October 17, 2024 | Volume: 60 | Issue: 1 | Pages: 83-89

10.1177/00185787241289281 | PMID 39544829 Get It

Background: Recent literature demonstrated a 24-hour reduction in vancomycin duration of therapy (DOT) for skin and soft tissue infections (SSTIs) with a negative methicillin-resistant staphylococcus aureus (MRSA) nasal screening versus a positive nasal screening. Objective of this study was to investigate vancomycin DOT in patients with SSTIs who received MRSA nasal polymerase chain reaction (PCR) screening versus those who did not receive MRSA nasal PCR screening. Methods: A retrospective, multi-center, cohort study was completed in admitted adult patients on vancomycin for SSTI from 01/01/2020 to 09/30/2022. Hospital policy permits any clinician to order a MRSA nasal PCR screening test for various indications, including SSTIs, pneumonia and sepsis. Results: One-hundred-fifty-one patients were included, of which 71 had MRSA nasal PCR screening tests obtained, and 80 did not. The median vancomycin DOT in patients with MRSA nasal PCR screening tests was 19.9 versus 36.7 hours ( P = .014) in patients without screening tests. Conclusion: Patients with SSTIs who receive MRSA nasal PCR screening tests have a shortened vancomycin DOT. These results contribute to current data in support of the efficacy and clinical utility of obtaining MRSA nasal PCR screening tests for SSTIs.